Researchers from Stanford, Johns Hopkins and U.C. San Diego Join Seven Bridges Scientists to Discuss Use of the CGC in their Precision Medicine Projects
As the amount of biomedical data increases worldwide, only a small fraction of it is immediately usable. The CGC makes petabytes of multidimensional data, including data from The Cancer Genomics Atlas (TCGA), more useful to researchers worldwide. The lunch panel will highlight the most exciting projects that have been enhanced using the CGC, which provides a central hub for research teams to store, analyze and jointly interpret their biomedical data in conjunction with large scale datasets from the TCGA. In another session, Gaurav Kaushik, Seven Bridges’ Scientific Program Manager, will discuss the computational challenges involved in analyzing hundreds of thousands of whole genomes, how the NCI pilot is attempting to solve some of these challenges, and the lessons learned. Details are as follows:
- WHAT: Reproducible Genomics at Scale: Making Use of TCGA and the NCI Cloud Pilots
- WHO: Dr. Gaurav Kaushik, Scientific Program Manager, Seven Bridges Dr. Erik Lehnert, Scientific Program Manager, Seven Bridges
- WHERE: Pan Pacific Vancouver Ocean Rooms 3/4 Vancouver Convention Center
- WHEN: Wednesday, October 19, 1 p.m.
- WHAT: Enabling Petabyte-Scale Genomics in the Cloud: Lessons from the NCI Cancer Genomics Cloud Pilots
- WHO: Dr. Gaurav Kaushik, Scientific Program Manager, Seven Bridges
- WHERE: Room 109 West Building, Vancouver Convention Center
- WHEN: Thursday, October 20, 9 a.m.
In addition to the CGC discussions, several Seven Bridges scientists will also present posters at ASHG 2016, which can be viewed Tuesday October 20, 2-3 p.m. and Wednesday October 21, 3-4 p.m. at the Vancouver Convention Center Exhibit Hall B, West Building. Poster presenters include:
- Kaushik Ghose
A Framework for Benchmarking Aligners and Variant Callers
- Wan-Ping Lee
Highly Accurate Alignment and Variant Calling by Using Population Genome Graphs
- Irina Glotova
Interactome-based Approach to Identification of Cancer Genes with Low Mutation Frequency
- Kaushik Ghose
“As the amount of biomedical data continues to increase exponentially, one of the research community’s biggest challenges is how to make this data immediately usable,” said James Sietstra, President of Seven Bridges. “We look forward to sharing what we’ve learned working on the NCI-CGC pilot, as well as other big initiatives like the Million Veteran Program and 100,000 Genomes Project, to make large-scale genomic research opportunities available to a broader range of scientists. So much is happening in the field of human genetics, and we are excited to join leading scientists and innovators from around the world at ASHG 2016 to exchange ideas and discuss the latest developments.”
The ASHG Annual Meeting is the largest human genetics meeting and exposition in the world, and this year is expected to attract over 6,500 scientific attendees and 200 exhibitors. The conference features invited presentations by the world’s leading geneticists, in addition to symposia, workshops, and abstract-driven sessions about cutting-edge developments in basic, translational, and clinical human genetics research and technology.
ASHG’s Annual Meeting also offers attendees the opportunity to view state-of-the-art medical and laboratory equipment, products, services, and computer software designed to enhance human genetics research, teaching, and consultation. Demos of the Seven Bridges Platform for cloud-based biomedical data analysis can be viewed at booth 1312 on the trade show floor. For more information about how Seven Bridges is making data useful, visit: http://www.sevenbridges.com/usefuldata.
About Seven Bridges
Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. The scalable, cloud-based Seven Bridges Platform empowers rapid, collaborative analysis of millions of genomes in concert with other forms of biomedical data. Thousands of researchers in government, biotech, pharmaceutical and academic labs use Seven Bridges, including three of the largest genomics projects in the world: U.S. National Cancer Institute’s Cancer Genomics Cloud pilot, the Million Veteran Program, and Genomics England’s 100,000 Genomes Project. As the NIH’s only commercial Trusted Partner, Seven Bridges authenticates and authorizes access to one of the world’s largest cancer genomics dataset. Named one of the world’s smartest companies by MIT Technology Review, Seven Bridges has offices in Cambridge, Mass.; Belgrade; London; Istanbul; and San Francisco.